| Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A … E Guttman-Yassky, PM Brunner, AU Neumann, S Khattri, AB Pavel, ... Journal of the American Academy of Dermatology 78 (5), 872-881. e6, 2018 | 311 | 2018 |
| The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins PM Brunner, M Suárez-Fariñas, H He, K Malik, HC Wen, J Gonzalez, ... Scientific reports 7 (1), 8707, 2017 | 234 | 2017 |
| Efficacy and safety of ustekinumab treatment in adults with moderate‐to‐severe atopic dermatitis S Khattri, PM Brunner, S Garcet, R Finney, SR Cohen, M Oliva, R Dutt, ... Experimental dermatology 26 (1), 28-35, 2017 | 227 | 2017 |
| Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population T Czarnowicki, J Gonzalez, A Shemer, D Malajian, H Xu, X Zheng, ... Journal of Allergy and Clinical Immunology 136 (1), 104-115. e7, 2015 | 218 | 2015 |
| Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology S Khattri, A Shemer, M Rozenblit, N Dhingra, T Czarnowicki, R Finney, ... Journal of Allergy and Clinical Immunology 133 (6), 1626-1634, 2014 | 194 | 2014 |
| Petrolatum: barrier repair and antimicrobial responses underlying this “inert” moisturizer T Czarnowicki, D Malajian, S Khattri, JC da Rosa, R Dutt, R Finney, ... Journal of Allergy and Clinical Immunology 137 (4), 1091-1102. e7, 2016 | 180 | 2016 |
| Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab PM Brunner, AB Pavel, S Khattri, A Leonard, K Malik, S Rose, SJ On, ... Journal of Allergy and Clinical Immunology 143 (1), 142-154, 2019 | 168 | 2019 |
| Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism E Guttman-Yassky, B Ungar, S Noda, M Suprun, A Shroff, R Dutt, S Khattri, ... Journal of Allergy and Clinical Immunology 137 (1), 301-304, 2016 | 95 | 2016 |
| A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis PM Brunner, S Khattri, S Garcet, R Finney, M Oliva, R Dutt, ... Journal of Allergy and Clinical Immunology 138 (1), 169-178, 2016 | 77 | 2016 |
| Nonlesional atopic dermatitis skin shares similar T‐cell clones with lesional tissues PM Brunner, RO Emerson, C Tipton, S Garcet, S Khattri, I Coats, ... Allergy 72 (12), 2017-2025, 2017 | 76 | 2017 |
| Statins and autoimmunity S Khattri, G Zandman-Goddard Immunologic research 56, 348-357, 2013 | 74 | 2013 |
| Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin JC da Rosa, D Malajian, A Shemer, M Rozenblit, N Dhingra, ... Journal of Allergy and Clinical Immunology 135 (3), 712-720, 2015 | 73 | 2015 |
| Rheumatic manifestations of autoimmune thyroid disease: the other autoimmune disease CE Tagoe, A Zezon, S Khattri The Journal of rheumatology 39 (6), 1125-1129, 2012 | 69 | 2012 |
| B-cell directed therapies in antiphospholipid antibody syndrome—new directions based on murine and human data S Khattri, G Zandman-Goddard, E Peeva Autoimmunity reviews 11 (10), 717-722, 2012 | 64 | 2012 |
| The role of intravenous immunoglobulins in the treatment of rheumatoid arthritis N Katz-Agranov, S Khattri, G Zandman-Goddard Autoimmunity reviews 14 (8), 651-658, 2015 | 60 | 2015 |
| Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients CE Tagoe, A Zezon, S Khattri, P Castellanos Rheumatology international 33, 1745-1752, 2013 | 56 | 2013 |
| Undertreatment of disease activity in systemic lupus erythematosus patients with endstage renal failure is associated with increased all-cause mortality A Broder, S Khattri, R Patel, C Putterman The Journal of rheumatology 38 (11), 2382-2389, 2011 | 38 | 2011 |
| Takotsubo cardiomyopathy due to iatrogenic methadone withdrawal FB Saiful, J Lafferty, CH Jun, S Teli, S Duvvuri, S Khattri, T Bhat Reviews in cardiovascular medicine 12 (3), 164-167, 2011 | 28 | 2011 |
| Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence M Rozenblit, M Suarez-Farinas, A Shemer, S Khattri, P Gilleaudeau, ... Journal of allergy and clinical immunology 134 (4), 955-957, 2014 | 27 | 2014 |
| Early onset of clinical improvement with ixekizumab in a randomized, open-label study of patients with moderate-to-severe plaque psoriasis S Khattri, O Goldblum, K Solotkin, Y Amir, MS Min, T Ridenour, FE Yang, ... The Journal of Clinical and Aesthetic Dermatology 11 (5), 33, 2018 | 19 | 2018 |
